|
1
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dong F, Liu T, Jin H and Wang W:
Chimaphilin inhibits human osteosarcoma cell invasion and
metastasis through suppressing the TGF-β1-induced
epithelial-to-mesenchymal transition markers via PI-3K/Akt, ERK1/2,
and Smad signaling pathways. Can J Physiol Pharmacol. 96:1–7. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang Y, Li L, Shao N, Hu Z, Chen H, Xu L,
Wang C, Cheng Y and Xiao J: Triazine-modified dendrimer for
efficient TRAIL gene therapy in osteosarcoma. Acta Biomater.
17:115–124. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bienemann K, Staege MS, Howe SJ,
Sena-Esteves M, Hanenberg H and Kramm CM: Targeted expression of
human folylpolyglutamate synthase for selective enhancement of
methotrexate chemotherapy in osteosarcoma cells. Cancer Gene Ther.
20:514–520. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu G, Liang Q and Liu Y: Primary
osteosarcoma of frontal bone: A case report and review of
literature. Medicine (Baltimore). 96:e93922017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu J, Zhang L, Ren Y, Gao Y, Kang L and
Qiao Q: Anticancer and immunoregulatory activity of Gynostemma
pentaphyllum polysaccharides in H22 tumor-bearing mice. Int J Biol
Macromol. 69:1–4. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li B, Wan L, Li Y, Yu Q, Chen P, Gan R,
Yang Q, Han Y and Guo C: Baicalin, a component of Scutellaria
baicalensis, alleviates anorexia and inhibits skeletal muscle
atrophy in experimental cancer cachexia. Tumour Biol.
35:12415–12425. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gao Z, Huang K and Xu H: Protective
effects of flavonoids in the roots of Scutellaria
baicalensis Georgi against hydrogen peroxide-induced oxidative
stress in HS-SY5Y cells. Pharmacol Res. 43:173–178. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ikezoe T, ChenS S, Heber D, Taguchi H and
Koeffler HP: Baicalin is a major component of PC-SPES which
inhibits the proliferation of human cancer cells via apoptosis and
cell cycle arrest. Prostate. 49:285–292. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shen YC, Chiou WF, Chou YC and Chen CF:
Mechanisms in mediating the anti-inflammatory effects of baicalin
and baicalein in human leukocytes. Eur J Pharmacol. 465:171–181.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dong LH, Wen JK, Miao SB, Jia Z, Hu HJ,
Sun RH, Wu Y and Han M: Baicalin inhibits PDGF-BB-stimulated
vascular smooth muscle cell proliferation through suppressing
PDGFRβ-ERK signaling and increase in p27 accumulation and prevents
injury-induced neointimal hyperplasia. Cell Res. 20:1252–1262.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen WC, Kuo TH, Tzeng YS and Tsai YC:
Baicalin induces apoptosis in SW620 human colorectal carcinoma
cells in vitro and suppresses tumor growth in vivo. Molecules.
17:3844–3857. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu Y, Pei M and Li L: Baicalin induces
apoptosis in hepatic cancer cells in vitro and suppresses tumor
growth in vivo. Int J Clin Exp Med. 8:8958–8967. 2015.PubMed/NCBI
|
|
14
|
Wang H, Li H, Chen F, Luo J, Gu J, Wang H,
Wu H and Xu Y: Baicalin extracted from Huangqin (Radix
Scutellariae Baicalensis) induces apoptosis in gastric cancer
cells by regulating B cell lymphoma (Bcl-2)/Bcl-2-associated X
protein and activating caspase-3 and caspase-9. J Tradit Chin Med.
37:229–235. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dou J, Wang Z, Ma L, Peng B, Mao K, Li C,
Su M, Zhou C and Peng G: Baicalein and baicalin inhibit colon
cancer using two distinct fashions of apoptosis and senescence.
Oncotarget. 9:20089–20102. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou T, Zhang A, Kuang G, Gong X, Jiang R,
Lin D, Li J and Li H, Zhang X, Wan J and Li H: Baicalin inhibits
the metastasis of highly aggressive breast cancer cells by
reversing epithelial-to-mesenchymal transition by targeting
β-catenin signaling. Oncol Rep. 38:3599–3607. 2017.PubMed/NCBI
|
|
17
|
Wang XF, Zhou QM, Du J, Zhang H, Lu YY and
Su SB: Baicalin suppresses migration, invasion and metastasis of
breast cancer via p38MAPK signaling pathway. Anticancer Agents Med
Chem. 13:923–931. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Z, Ma L, Su M, Zhou Y, Mao K, Li C,
Peng G, Zhou C, Shen B and Dou J: Baicalin induces cellular
senescence in human colon cancer cells via upregulation of DEPP and
the activation of Ras/Raf/MEK/ERK signaling. Cell Death Dis.
9:2172018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Q, Xu H and Zhao X: Baicalin inhibits
human cervical cancer cells by suppressing protein kinase C/signal
transducer and activator of transcription (PKC/STAT3) signaling
pathway. Med Sci Monit. 24:1955–1961. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wan D and Ouyang H: Baicalin induces
apoptosis in human osteosarcoma cell through ROS-mediated
mitochondrial pathway. Nat Prod Res. 32:1996–2000. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Y, Wang H, Zhou R, Zhong W, Lu S, Ma
Z and Chai Y: Baicalin inhibits human osteosarcoma cells invasion,
metastasis, and anoikis resistance by suppressing the transforming
growth factor-β1-induced epithelial-to-mesenchymal transition.
Anticancer Drugs. 28:581–587. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Abeyrathna P and Su Y: The critical role
of Akt in cardiovascular function. Vascul Pharmacol. 74:38–48.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Martini M, De Santis MC, Braccini L,
Gulluni F and Hirsch E: PI3K/AKT signaling pathway and cancer: An
updated review. Ann Med. 46:372–383. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Porta C, Paglino C and Mosca A: Targeting
PI3K/Akt/mTOR signaling in cancer. Front Oncol. 4:642014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang J, Yu XH, Yan YG, Wang C and Wang
WJ: PI3K/Akt signaling in osteosarcoma. Clin Chim Acta.
444:182–192. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou Y, Zhu LB, Peng AF, Wang TF, Long XH,
Gao S, Zhou RP and Liu ZL: LY294002 inhibits the malignant
phenotype of osteosarcoma cells by modulating the
phosphatidylinositol 3-kinase/Akt/fatty acid synthase signaling
pathway in vitro. Mol Med Rep. 11:1352–1357. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang B, Li YL, Zhao JL, Zhen O, Yu C,
Yang BH and Yu XR: Hypoxia-inducible factor-1 promotes cancer
progression through activating AKT/Cyclin D1 signaling pathway in
osteosarcoma. Biomed Pharmacother. 105:1–9. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ren L, Hong ES, Mendoza A, Issaq S, Tran
Hoang C, LeBlanc A and Khanna C: Metabolomics uncovers a link
between inositol metabolism and osteosarcoma metastasis.
Oncotarget. 8:38541–38553. 2017.PubMed/NCBI
|
|
29
|
Zhang Y, Hu H, Song L, Cai L, Wei R and
Jin W: Epirubicin-mediated expression of miR-302b is involved in
osteosarcoma apoptosis and cell cycle regulation. Toxicol Lett.
222:1–9. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang K, Tian F, Zhang Y, Zhu Q, Xue N,
Zhu H, Wang H and Guo X: MACC1 is involved in the regulation of
proliferation, colony formation, invasion ability, cell cycle
distribution, apoptosis and tumorigenicity by altering Akt
signaling pathway in human osteosarcoma. Tumour Biol. 35:2537–2548.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li G, Cai M, Fu D, Chen K, Sun M, Cai Z
and Cheng B: Heat shock protein 90B1 plays an oncogenic role and is
a target of microRNA-223 in human osteosarcoma. Cell Physiol
Biochem. 30:1481–1490. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Atif F, Yousuf S and Stein DG: Anti-tumor
effects of progesterone in human glioblastoma multiforme: Role of
PI3K/Akt/mTOR signaling. J Steroid Biochem Mol Biol. 146:62–73.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhuo B, Li Y, Li Z, Qin H, Sun Q, Zhang F,
Shen Y, Shi Y and Wang R: PI3K/Akt signaling mediated Hexokinase-2
expression inhibits cell apoptosis and promotes tumor growth in
pediatric osteosarcoma. Biochem Biophys Res Commun. 464:401–406.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang Y, Wan D, Zhou R, Zhong W, Lu S and
Chai Y: Geraniin inhibits migration and invasion of human
osteosarcoma cancer cells through regulation of PI3K/Akt and ERK1/2
signaling pathways. Anticancer Drugs. 28:959–966. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Angulo P, Kaushik G, Subramaniam D,
Dandawate P, Neville K, Chastain K and Anant S: Natural compounds
targeting major cell signaling pathways: A novel paradigm for
osteosarcoma therapy. J Hematol Oncol. 10:102017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee J and Kim JH: Kaempferol inhibits
pancreatic cancer cell growth and migration through the blockade of
EGFR-related pathway in vitro. PLoS One. 11:e01552642016.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li L, Wei L, Shen A, Chu J, Lin J and Peng
J: Oleanolic acid modulates multiple intracellular targets to
inhibit colorectal cancer growth. Int J Oncol. 47:2247–2254. 2015.
View Article : Google Scholar : PubMed/NCBI
|
